Brief: Hybrigenics: First Favorable Decision In Appeal Against U.S. Patent For USP7 Inhibitors
25/05/2020 07:20
May 25 (Reuters) - HYBRIGENICS SA ALHYG.PA :
* FIRST FAVORABLE DECISION IN THE APPEAL AGAINST A U.S.
PATENT FOR
USP7 INHIBITORS
* FORMA THERAPEUTICS ASSIGNED THIS PATENT TO INTEGRAL EARLY
DISCOVERY INC, A BOSTON-BASED BIOTECH START-UP, WHICH APPEALED
THE DECISION
Source text for Eikon: ID:nNDL2BtZrd
Further company coverage: ALHYG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Aton SA
See all newsBrief: Hybrigenics SA Says Hybrigenics Re-Brands To 'Aton', Commits EUR 15Million To Support Its New Growth And Development Strategy Over Next Three Years
Brief: Hybrigenics 2022 Net Loss EUR 0.5 Million
Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
Brief: Hybrigenics Targets EUR 60 Mln Of Turnover By 2025
Brief: Hybrigenics H1 Operating Loss Widens To EUR 0.2 Million